Iol chemicals & pharmaceuticals Financial Statements

IOLCP Ratio Analysis

  • Tabular Data
  • Graph
  • Consolidated
  • Standalone
Y/e 31 Mar Mar-2022 - - -
Growth matrix (%)        
Revenue growth -- -- -- --
Op profit growth -- -- -- --
EBIT growth -- -- -- --
Net profit growth -- -- -- --
Profitability ratios (%)        
OPM 11.80 -- -- --
EBIT margin 11.30 -- -- --
Net profit margin 7.68 -- -- --
RoCE -- -- -- --
RoNW -- -- -- --
RoA -- -- -- --
Per share ratios ()        
EPS 28.60 -- -- --
Dividend per share 4 -- -- --
Cash EPS 21.20 -- -- --
Book value per share 237 -- -- --
Valuation ratios        
P/E 12.40 -- -- --
P/CEPS 16.70 -- -- --
P/B 1.49 -- -- --
EV/EBIDTA 6.82 -- -- --
Payout (%)        
Dividend payout 21 -- -- --
Tax payout (24) -- -- --
Liquidity ratios        
Debtor days -- -- -- --
Inventory days -- -- -- --
Creditor days -- -- -- --
Leverage ratios        
Interest coverage (30) -- -- --
Net debt / equity (0.10) -- -- --
Net debt / op. profit (0.40) -- -- --
Cost breakup ()        
Material costs (72) -- -- --
Employee costs (6.50) -- -- --
Other costs (9.80) -- -- --

OPEN A DEMAT ACCOUNT & Get
FREE Benefits Worth 5,000

Open Demat Account
  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity